Pleomorphic Giant Cell Carcinoma of Urinary Bladder with Brain Metastases Despite Initial Response to Cisplatin and Gemcitabine: A Case Report
DOI:
https://doi.org/10.17140/UAOJ-4-133Keywords:
Urinary bladder, Brain metastases despite, Cisplatin and gemcitabine, Tumour, Urothelial carcinomaAbstract
A 59-year-old male presented with haematuria and was diagnosed with pleomorphic giant cell carcinoma of the urinary bladder, a
very rare variant of urothelial carcinoma. The tumour was staged at pT2N3M1 and the primary tumour was removed by transure
thral resection, and nodal metastases were treated with the standard systemic cisplatin and gemcitabine for urothelial cell carcinoma
of the bladder. This treatment rendered the tumour clinically undetectable. Despite this treatment the patient developed brain
metastases which were not found until the patient presented with neurological symptoms. This is the first recorded case of brain metastases from pleomorphic giant cell carcinoma of the urinary bladder recorded in the literature. CT imaging of the brain should
be considered in the follow-up in patients with this tumour.
References
Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: Prostate and bladder tumours. Eur Urol. 2016; 70: 106-119, doi: 10.1016/j.eururo.2016.02.028
Samaratunga H, Delahunt B. Recently described and unusual variants of urothelial carcinoma of the urinary bladder. Pathology. 2012; 44: 407-418, doi: 10.1097/PAT.0b013e3283560172
Lopez-Beltran A, Eble JN, Bostwick D. G. Pleomorphic giant cell carcinoma of the prostate. Arch Pathol Lab Med. 2005; 129(5): 683-685. doi: 10.1043/1543-2165(2005)129<0683:PGCCOT>2.0 .CO;2
Kir G, Seneldi, H, Topal CS, Tosun M. Pleomorphic giant cell 49 Vega Vega A et al carcinoma of the prostate: A case report. Virchows Arch. 2015; 467: S277-S277.
Parwani AV, Herawi M, Epstein JI. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases. Am J Surg Pathol. 2006; 30: 1254-1259. doi: 10.1097/01.pas.0000209841.77595.4b
Samaratunga H, Delahunt B, Egevad L, Adamson M, Hussey D, Malone G, et al. Pleomorphic giant cell carcinoma of the urinary bladder: An extreme form of tumour de-differentiation. Histopathology. 2016; 68: 533-540. doi: 10.1111/his.12785
Akkaya H, Ipekci T, Hoscan MB, Ozdemir H. Pleomorphic giant cell carcinoma of the urinary bladder: Report of two cases. Virchows Arch. 2015; 467: S263-S264.
Alexiev BA, Papadimitriou JC, Chai TC, Ramos E, Staats PN, Drachenberg CB, et al. Polyomavirus (BK)-associated pleomorphic giant cell carcinoma of the urinary bladder: A case report. Pathol Res Pract. 2013; 209: 255259. doi: 10.1016/j.prp.2013.01.008
Barresi V. HOXB13 is not expressed in pleomorphic giant cell carcinoma of the bladder. Virchows Arch. 2018; 473: 259-260. doi:
1007/s00428-018-2394-1 10. Lopez-Beltran A, Blanca A, Montironi R, Cheng L, López JCR. Pleomorphic giant cell carcinoma of the urinary bladder. Human Pathology. 2009; 40: 1461-1466. doi: 10.1016/j.humpath.2009.02.016
Amin MB. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Modern Pathology. 2009; 22: S96. doi: 10.1038/modpathol.2009.26
Lopez-Beltran A, Cheng L, Comperat E, Rouprêt M, Blanca A, Menendez CL, et al. Large cell undifferentiated carcinoma of the urinary bladder. Pathology. 2010; 42: 364-368. doi: 10.3109/00313021003767363
Lopez-Beltran A, Requena MJ, Cheng L, Montironi R. Pathological variants of invasive bladder cancer according to their suggested clinical significance. B J U Int. 2008; 101: 275-281. doi: 10.1111/j.1464-410X.2007.07271.x
Mahmoud-Ahmed AS, Suh JH, Kupelian PA, Klein EA, Peereboom DM, Dreicer R, et al. Brain metastases from bladder carcinoma: Presentation, treatment and survival. J Urol. 2002; 167: 2419-2422. doi: 10.1016/S0022-5347(05)64996-8
Chung JH, Lee JY, Pyo JY, Oh YH, Lee SW, Moon HS, et al. Brain and skin metastasis from urothelial carcinoma of the bladder. Korean J Urol. 2013; 54: 66-68. doi: 10.4111/kju.2013.54.1.66
Sarmiento JM, Wi MS, Piao Z, Stiner ES. Solitary cerebral metastasis from transitional cell carcinoma after a 14-year remission of urinary bladder cancer treated with gemcitabine: Case report and literature review. Surg Neurol Int. 2012; 3: 82. doi: 10.4103/2152-7806.99172
Vaa B, Kohli M, Price KA, Swetz KM. Solitary cystic cerebellar metastasis in a patient with invasive transitional cell carcinoma of the bladder. BMJ Case Reports. 2014; 2014: bcr2013200137. doi: 10.1136/bcr-2013-200137
Anderson RS, el-Mahdi AM, Kuban DA, Higgins EM. Brain metastases from transitional cell carcinoma of urinary bladder. Urology. 1992; 39: 17-20. doi: 10.1016/0090-4295(92)90034-t
Johnson JD, Young, B. Demographics of brain metastasis. Neurosurg Clin N Am. 1996; 7: 337-344. doi: 10.1016/S1042- 3680(18)30365-6
Yang G, Wang Y, Wang Y, Lin S, Sun D. CyberKnife therapy of 24 multiple brain metastases from lung cancer: A case report. Oncol Lett. 20132; 6: 534-536. doi: 10.3892/ol.2013.1383
Shinagare AB, Ramaiya NH, Jagannathan JP, Fennessy FM, Taplin M-E, Van den Abbeele AD. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. Submit your article to this journal | https://openventio.org/submit-manuscript/ Case Report | Volume 4 | Number 3| Vega Vega A et al AJR Am J Roentgenol. 2011; 196: 117-122. doi: 10.2214/AJR.10.5036
Bamias A, Tiliakos I, Karali MD, Dimopoulos MA. Systemic chemotherapy in inoperable or metastatic bladder cancer. Ann Oncol. 2006; 17: 553-561. doi: 10.1093/annonc/mdj079
Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee J-L, Fong L, et al. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med. 2017; 376: 1015-1026. doi: 10.1056/ NEJMoa1613683
Winters BR, Wright JL, Holt SK, Dash A, Gore JL, Schade GR. Health related quality of life following radical cystectomy: Comparative analysis from the medicare health outcomes survey. J Urolo. 2018; 199: 669-675. doi: 10.1016/j.juro.2017.08.111
Samaratunga H. Pleomorphic giant cell carcinoma of the urinary bladder: A clinicopathological analysis of 13 cases. Mod Pathol. 2015; 28: 255A-256A.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Urology and Andrology (UA) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
